ESC Premium Access

Anticoagulation in atrial fibrillation

Event: ESC CONGRESS 2017
Topic: Atrial fibrillation (AF)
Session type: Rapid Fire Abstracts
Date: 29 August 2017
Time: 14:00 - 15:30

Session

10 presentations in this session

Atrial fibrillation and venous thromboembolism. a Swedish nationwide registry study on 1358274 individuals.

Speaker: Assistant Professor B. Hornestam (Gothenburg, SE)
Thumbnail

Higher risk of dementia without oral anticoagulation in atrial fibrillation

Speaker: Associate Professor L. Friberg (Bromma, SE)
Thumbnail

Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease

Speaker: Doctor P. Noseworthy (Rochester, US)
Thumbnail

Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants

Speaker: Doctor P. Noseworthy (Rochester, US)
Thumbnail

Similar long-term risk of thromboembolic events in postoperative atrial fibrillation following coronary artery bypass grafting and non-valvular atrial fibrillation: need for anticoagulation?

Speaker: Mr J. Butt (Copenhagen, DK)
Thumbnail

Incidence, predictors and prognosis of thrombus formation on device in patients with atrial fibrillation after left atrial appendage occlusion for stroke prevention in a multicenter analysis.

Speaker: Professor L. Fauchier (Tours, FR)
Thumbnail

Edoxaban versus warfarin in patients with atrial fibrillation in relation to stroke risk. A subanalysis of the ENGAGE AF-TIMI 48 study

Speaker: Doctor J. De Groot (Amsterdam, NL)
Thumbnail

Fatal and non-fatal secondary events in 496173 individuals with a first episode of atrial fibrillation between 1987 and 2013- a Swedish register study

Speaker: Associate Professor L. Bjorck (Goteborg, SE)
Thumbnail

Comparison of stroke and major bleeding risk of treatment with apixaban vs. rivaroxaban and dabigatran among elderly nonvalvular atrial fibrillation patients in the United States

Speaker: Doctor S. Deitelzweig (New Orleans, US)
Thumbnail

Correlation of the CHADS2, CHA2DS2-Vasc and ATRIA risk scores with the presence of left atrial appendage thrombus in patients with non-valvular atrial fibrillation.

Speaker: Doctor A. Rueda Linares (Madrid, ES)
Thumbnail

10 speakers from this session

Assistant Professor Bjorn Hornestam

Sahlgrenska Academy, Gothenburg (Sweden)
0 follower

Associate Professor Leif Friberg

Friberg Research Ab, Bromma (Sweden)
1 presentation
0 follower

Doctor Peter Noseworthy

Mayo Clinic, Rochester (United States of America)
1 presentation
0 follower

Doctor Peter Noseworthy

Mayo Clinic, Rochester (United States of America)
1 presentation
0 follower

Mr Jawad Haider Butt

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

Professor Laurent Fauchier

Tours Regional University Hospital, Hospital Trousseau, Tours (France)
12 presentations
1 follower

Doctor Joris R De Groot

Amsterdam University Medical Center, Amsterdam (Netherlands (The))
9 presentations
0 follower

Associate Professor Lena Bjorck

Sahlgrenska Academy - University of Gothenburg, Goteborg (Sweden)
0 follower

Doctor Steven Deitelzweig

Ochsner Clinic Foundation, New Orleans (United States of America)
3 presentations
0 follower

Doctor Andrea Rueda Linares

Gomez Ulla Central Defense Hospital, Madrid (Spain)
0 follower

This platform is supported by

logo Novo Nordisk